INNT
TOTAL INVALIDATION PROCESSED BY THE IB
07/30/2026
Back to search
Official data from USPTO
TENDO-CELL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
07/30/2026
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
01/22/2018
Registration date
09/25/2018
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/11/2025
Last transaction
07/30/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
78
Owner location
BE
Examiner
BLANDU, FLORENTINA
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Boehringer Ingelheim Veterinary Medicine Belgium, naamloze vennootschap
GLOBAL STEM CELL TECHNOLOGY, besloten vennootschap met beperkte aansprakelijkheid
Representatives
BAP IP bvba - Brantsandpatents
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Stem cells for veterinary use; surgical implants comprising living tissue and grown from stem cells; veterinary preparations for the prevention and treatment of tendon and muscle damage and injuries; vitamin preparations for the purpose of supporting stem cell physiology; dietary supplements for the purpose of supporting stem cell physiology; pharmaceutical preparationsin the form of injectable gelspowderstablets and fluids for preventing and treating of tendon and muscle damage and injuries for humans and animals
Publications
History of USPTO decisions and trademark events.
35 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
07/05/2026
XXCR
GENERIC MADRID TRANSACTION CREATED
07/05/2026
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
12/11/2025
C71T
CANCELLED SECTION 71
04/11/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/03/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
12/31/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/25/2020
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
02/02/2019
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
01/24/2019
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
01/11/2019
XXCR
GENERIC MADRID TRANSACTION CREATED
01/11/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/25/2018
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/04/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
09/25/2018
GPNX
NOTIFICATION PROCESSED BY IB
07/21/2018
PUBO
PUBLISHED FOR OPPOSITION
07/10/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/04/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/04/2018
NPUB
NOTICE OF PUBLICATION
06/20/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/05/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/04/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/04/2018
ALIE
ASSIGNED TO LIE
05/31/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/25/2018
RFNT
REFUSAL PROCESSED BY IB
05/25/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/10/2018
RFRR
REFUSAL PROCESSED BY MPU
05/10/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/08/2018
CNRT
NON-FINAL ACTION WRITTEN
05/07/2018
DOCK
ASSIGNED TO EXAMINER
05/02/2018
MAFR
APPLICATION FILING RECEIPT MAILED
03/31/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/27/2018
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
03/23/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/22/2018
Continuous trademark protection
Get notified about every new filing that threatens TENDO-CELL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.